Please check the individual session for location or broadcast availability.
Saira Khaderi, MD, MPH
Target Audience and Needs
Hepatologists, gastroenterologists, thoracic and transplant surgeons, medical oncologists, interventional radiologists, advanced practice providers, fellows, residents, and healthcare professionals in related disciplines need to receive regular updates on advances in hepatology, innovations in diagnostic imaging techniques, and developments in the management of liver tumors. The tumor board aims to use a multidisciplinary team approach and complex case reviews to increase understanding and application of diagnostic criteria specific to hepatocellular carcinoma and other liver conditions and of the Milan criteria for liver transplantation. The tumor board also aims to enhance the quality of hepatology care, facilitate better physician-patient communication, and improve patient outcomes.
Educational methods will include case presentations and panel discussion.
At the conclusion of the sessions, the participants should be able to:
- Use a multidisciplinary team approach to develop treatment plans and interventions for patients with liver diseases.
- Identify the imaging characteristics of hepatocellular carcinoma and other liver conditions.
- Describe the Milan criteria for liver transplantation and apply them properly.
- Choose appropriate follow-up imaging studies based on type of liver disease and intervention.
- Apply evidence-based strategies to improve physician-patient communication and patient education.
Participants may be asked to complete a session evaluation.
Baylor College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Baylor College of Medicine designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.